Concurrent vs sequential chemoradiotherapy for patients with advanced non–small-cell lung cancer
Sign Up to like & getrecommendations! Published in 2021 at "Medicine"
DOI: 10.1097/md.0000000000021455
Abstract: Supplemental Digital Content is available in the text Abstract Background: Chemotherapy in combination with thoracic radiotherapy yields significant results in patients with advanced non–small-cell lung cancer (NSCLC) compared with thoracic radiotherapy alone. However, whether concurrent… read more here.
Keywords: sequential chemoradiotherapy; concurrent chemoradiotherapy; chemoradiotherapy; concurrent sequential ... See more keywords
Accelerated, Dose escalated, Sequential Chemoradiotherapy in Non-small-cell lung cancer (ADSCaN): a protocol for a randomised phase II study
Sign Up to like & getrecommendations! Published in 2019 at "BMJ Open"
DOI: 10.1136/bmjopen-2017-019903
Abstract: Introduction Lung cancer is the most common cause of cancer mortality in the UK, and non-small-cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancers. Most patients present with inoperable disease; therefore, radiotherapy… read more here.
Keywords: sequential chemoradiotherapy; chemoradiotherapy; study; lung cancer ... See more keywords
Elderly Patients with Locally Advanced and Unresectable Non-Small-Cell Lung Cancer May Benefit from Sequential Chemoradiotherapy
Sign Up to like & getrecommendations! Published in 2021 at "Cancers"
DOI: 10.3390/cancers13184534
Abstract: Simple Summary The combination of chemotherapy and radiotherapy, compared with radiotherapy alone, reduces the risk of local disease recurrence and the risk of distant metastases in patients with locally advanced unresectable non-small-cell lung cancer. Concurrent… read more here.
Keywords: sequential chemoradiotherapy; locally advanced; chemoradiotherapy; lung cancer ... See more keywords